Clinical Trials Browser

Gestational Trophoblastic Disease × camrelizumab × Clear all

NCT05139095 2026-02-05

Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia

Phase 2 Recruiting

Gestational Trophoblastic Disease

NCT04812002 2022-06-03

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Phase 2 Recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Gestational Trophoblastic Disease

NCT04047017 2021-07-30

GTN

Phase 2 Completed

Recurrence, Gestational Trophoblastic Disease